Trials / Not Yet Recruiting
Not Yet RecruitingNCT07396116
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
Preoperative Hypofractionated Radiotherapy Combined With Immunotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-02)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy combined with immunotherapy followed by surgery for retroperitoneal sarcoma
Conditions
- Soft Tissue Sarcoma (STS)
- Retroperitoneal Sarcoma
- Immunotherapy
- Radiotherapy Side Effect
- Ultra-hypofractionated Radiotherapy
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | ultra-hypofractionated radiotherapy combined with immunotherapy | ultra-hypo-fractionated radiotherapy with 43.5Gy in 15 fractions combined with immunotherapy, followed by surgery done at 6 to 10 weeks post-RT |
Timeline
- Start date
- 2026-02-12
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2026-02-09
- Last updated
- 2026-02-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07396116. Inclusion in this directory is not an endorsement.